Chongqing Pharscin Pharmaceutical Co., Ltd.

¥12.94As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002907Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR 0.57%
Div yield 0.58%
ROE 4.54%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.11)
PE TTM 57.58
TSR TTM (20.50%)
Mkt cap ¥5.404B
ROIC 4.75%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
0.59%
3.33%
Hold 10|11|3|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.16
0.17
0.16
0.15
20.13%
23.47%
15.87%
0.87%
Revenue¥M
352.6
362.1
371.6
367.0
9.99%
12.81%
11.76%
6.71%
Peers (US$810.0M)
Cap (US$)
PE
806.9M
112.9x
Capital
TTM
5Y
10Y
Leveragex
2.460
1.104
0.941
EBIT/Intx
2.331
0.351
0.304
Own earn%
51.12
(1.54)
5.89
Sh yield%
39.02
33.82
32.55
Owners
Insiders/Inst%
13.04
43.19
Short interest%
2.21
SBC / revenue%
2.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
20–28
$1 testx
0.0
Incr. ROIC%
4